Schnitzer TJ, et al. Efficacy and Safety of Subcutaneous Tanezumab for the Treatment of Osteoarthritis of the Hip or Knee. ACR 2018, abstract L20.
Ziekteactiviteit beoordelen met DAPSA op basis van 28 gewrichten
dec 2018 | Arthritis psoriatica
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE